Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10811678rdf:typepubmed:Citationlld:pubmed
pubmed-article:10811678lifeskim:mentionsumls-concept:C1516213lld:lifeskim
pubmed-article:10811678lifeskim:mentionsumls-concept:C0035608lld:lifeskim
pubmed-article:10811678lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:10811678lifeskim:mentionsumls-concept:C0199176lld:lifeskim
pubmed-article:10811678lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:10811678lifeskim:mentionsumls-concept:C1533693lld:lifeskim
pubmed-article:10811678lifeskim:mentionsumls-concept:C0206034lld:lifeskim
pubmed-article:10811678pubmed:issue10lld:pubmed
pubmed-article:10811678pubmed:dateCreated2000-6-15lld:pubmed
pubmed-article:10811678pubmed:abstractTextTo determine whether the addition of rifampin to a quinolone-based antibacterial prophylactic regimen in patients undergoing high-dose chemotherapy (HDC) with peripheral-blood stem-cell transplantation (PBSCT) decreases the incidence of neutropenia and fever, Gram-positive bacteremia, and infection-related morbidity.lld:pubmed
pubmed-article:10811678pubmed:languageenglld:pubmed
pubmed-article:10811678pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10811678pubmed:citationSubsetIMlld:pubmed
pubmed-article:10811678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10811678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10811678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10811678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10811678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10811678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10811678pubmed:statusMEDLINElld:pubmed
pubmed-article:10811678pubmed:monthMaylld:pubmed
pubmed-article:10811678pubmed:issn0732-183Xlld:pubmed
pubmed-article:10811678pubmed:authorpubmed-author:HidalgoMMlld:pubmed
pubmed-article:10811678pubmed:authorpubmed-author:RodriguezMMlld:pubmed
pubmed-article:10811678pubmed:authorpubmed-author:Cortés-FunesH...lld:pubmed
pubmed-article:10811678pubmed:authorpubmed-author:SalazarRRlld:pubmed
pubmed-article:10811678pubmed:authorpubmed-author:LumbrerasCClld:pubmed
pubmed-article:10811678pubmed:authorpubmed-author:SoláCClld:pubmed
pubmed-article:10811678pubmed:authorpubmed-author:PerduDDlld:pubmed
pubmed-article:10811678pubmed:authorpubmed-author:HornedoJJlld:pubmed
pubmed-article:10811678pubmed:authorpubmed-author:ArcedianoAAlld:pubmed
pubmed-article:10811678pubmed:authorpubmed-author:ValentíVVlld:pubmed
pubmed-article:10811678pubmed:authorpubmed-author:Gomez-MartinC...lld:pubmed
pubmed-article:10811678pubmed:issnTypePrintlld:pubmed
pubmed-article:10811678pubmed:volume18lld:pubmed
pubmed-article:10811678pubmed:ownerNLMlld:pubmed
pubmed-article:10811678pubmed:authorsCompleteYlld:pubmed
pubmed-article:10811678pubmed:pagination2126-34lld:pubmed
pubmed-article:10811678pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:meshHeadingpubmed-meshheading:10811678...lld:pubmed
pubmed-article:10811678pubmed:year2000lld:pubmed
pubmed-article:10811678pubmed:articleTitleRifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.lld:pubmed
pubmed-article:10811678pubmed:affiliationDivision of Medical Oncology, Microbiology, and Infectious Disease, Hospital Universitario "12 de Octubre," Madrid, Spain.lld:pubmed
pubmed-article:10811678pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10811678pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10811678pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10811678pubmed:publicationTypeMulticenter Studylld:pubmed